Substances such as berberine, which has glucose-lowering properties, or stimulant-based fat burners, could interact unpredictably with retatrutide's metabolic effects
The information below comes from published clinical trial protocols only
Those include Ozempic and its sister drug approved for obesity, Wegovy, which use semaglutide, and Mounjaro and Zepbound, for diabetes and obesity, respectively, which use the active ingredient tirzepatide
However, this greater efficacy sometimes comes with a higher incidence of gastrointestinal side effects during dose escalation
Semaglutide has been shown to help patients achieve substantial weight loss, better blood sugar control, and improved appetite regulation
These events feature healthcare providers, peptide experts, and community leaders sharing valuable insights on longevity and wellness